Capecitabine and bevacizumab with or without vinorelbine in first-line treatment of HER2/neu-negative metastatic or locally advanced breast cancer: final efficacy and safety data of the randomised, open-label superiority phase 3 CARIN trial. 7. Juni 2016 Welt, A., Marschner, N., Lerchenmueller, C., Decker, T., Steffens, C.-C., Koehler, A., Depenbusch, R., Busies, S., Hegewisch-Becker, S., 2016. Breast Cancer Res Treat 156, 97–107. doi:10.1007/s10549-016-3727-x Abstract Antianemic Treatment of Cancer Patients in German Routine Practice: Data from a Prospective Cohort – The Tumor Anemia Registry. Steinmetz, T., Schröder, J., Plath, M., Link, H., Vogt, M., Frank, M., Marschner, N., 2016. Anemia 2016, e8057650. doi:10.1155/2016/8057650 Abstract… Weiterlesen Dermatux: Phase IV trial of C-FOLFIRI in 1st-line metastatic colorectal cancer receiving a pre-defined skin care. Schimanski, C.C., Staib, F., Goehler, T., Hebart, H.F., Neise, M., Rudi, J., Geer, T., Ehscheidt, P., Flohr, T., Schmittel, A.H., Galle, P.R., Moehler, M.H., 2016. Weiterlesen